Ever since Biogen and Eisai’s Aduhelm (aducanemab) was approved in 2021 as the first antibody to treat Alzheimer’s disease by ...

Learn how AI and machine learning enhance antibody discovery – from structure prediction to binding optimization – with robust data and lab informatics.

A new article in the peer-reviewed journal Nucleic Acid Therapeutics describes the characterization of antibodies targeting ...

Hybridoma sequencing offers several key advantages that make it an essential tool for ensuring the reliability, scalability, and long-term value of monoclonal antibody research.

VISTA, an AI-controlled data loop system, guides large-scale antibody design from scratch for applications in cancer therapy.

Learn how AI and machine learning enhance antibody discovery – from structure prediction to binding optimization – with robust data and lab informatics.

A new article in the peer-reviewed journal Nucleic Acid Therapeutics describes the characterization of antibodies targeting ...

The antibodies licensed under this agreement were discovered using our proprietary RenMice ® fully human antibody platform, highlighting our ability to empower partners in driving innovative drug ...

BEIJING — Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with ...

‘Stratus’ is the nickname for Covid variant XFG which is spreading across the world ...